Date published: 2025-10-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Stem-Cell Factor/c-Kit Inhibitor, ISCK03 (CAS 945526-43-2)

5.0(1)
Write a reviewAsk a question

See product citations (4)

Alternate Names:
4-t-Butylphenyl-N-(4-imidazol-1-yl-phenyl)sulfonamide; SCF/c-Kit Signaling Inhibitor
Application:
Stem-Cell Factor/c-Kit Inhibitor, ISCK03 is a c-kit activity inhibitor
CAS Number:
945526-43-2
Purity:
≥97%
Molecular Weight:
355.5
Molecular Formula:
C19H21N3O2S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Stem-Cell Factor/c-Kit Inhibitor, ISCK03, is a small molecule chemical primarily recognized for its targeted inhibition of the c-Kit receptor tyrosine kinase. This specific action disrupts the signaling pathways crucial for the growth and survival of certain cell types, particularly those involved in early stem cell and progenitor cell development. ISCK03 has been pivotal in studying the c-Kit signaling mechanism under controlled laboratory conditions. By blocking the c-Kit receptor, ISCK03 serves as a tool to explain the roles of this kinase in cellular processes such as proliferation, differentiation, and apoptosis in various cell types. This is particularly significant in hematopoiesis and melanogenesis, where c-Kit plays a crucial role. The ability of ISCK03 to specifically inhibit c-Kit has also made it valuable in stem cell research. It is used to investigate the maintenance and function of stem cells in various tissues, providing insights into the cellular mechanisms that could potentially influence stem cell behavior and lineage specification. Moreover, in developmental biology studies, ISCK03 helps in understanding how interruptions in c-Kit signaling can affect organogenesis and tissue repair mechanisms. Furthermore, the inhibitor′s role extends to its utility in molecular biology and biochemistry research settings, where it is employed to dissect the biochemical pathways mediated by c-Kit. This includes studying the downstream effects of c-Kit inhibition on cellular signaling cascades, such as those involving PI3K/AKT and MAPK, which are vital for cell cycle regulation and survival signals.


Stem-Cell Factor/c-Kit Inhibitor, ISCK03 (CAS 945526-43-2) References

  1. [4-t-butylphenyl]-N-(4-imidazol-1-yl phenyl)sulfonamide (ISCK03) inhibits SCF/c-kit signaling in 501mel human melanoma cells and abolishes melanin production in mice and brownish guinea pigs.  |  Na, YJ., et al. 2007. Biochem Pharmacol. 74: 780-6. PMID: 17658483
  2. Comparison of the effects of carbon ion and photon irradiation on the angiogenic response in human lung adenocarcinoma cells.  |  Kamlah, F., et al. 2011. Int J Radiat Oncol Biol Phys. 80: 1541-9. PMID: 21621345
  3. Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression.  |  Hirano, T., et al. 2015. Mol Cancer. 14: 90. PMID: 25928165
  4. In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed.  |  Eberle, F., et al. 2017. Clin Transl Radiat Oncol. 2: 69-75. PMID: 29658004
  5. SCF/c-kit signaling pathway participates in ICC damage in neurogenic bladder.  |  Ma, Y., et al. 2020. Cell Cycle. 19: 2074-2080. PMID: 32658594
  6. c-KIT-ERK1/2 signaling activated ELK1 and upregulated carcinoembryonic antigen expression to promote colorectal cancer progression.  |  Ma, J., et al. 2021. Cancer Sci. 112: 655-667. PMID: 33247506
  7. Long noncoding RNA CCDC26 as a modulator of transcriptional switching between fetal and embryonic globins.  |  Hirano, T., et al. 2021. Biochim Biophys Acta Mol Cell Res. 1868: 118931. PMID: 33340546
  8. Enhanced glycolysis in granulosa cells promotes the activation of primordial follicles through mTOR signaling.  |  Zhang, X., et al. 2022. Cell Death Dis. 13: 87. PMID: 35087042
  9. The metallic compound promotes primordial follicle activation and ameliorates fertility deficits in aged mice.  |  Han, L., et al. 2023. Theranostics. 13: 3131-3148. PMID: 37351158
  10. PGR-KITLG signaling drives a tumor-mast cell regulatory feedback to modulate apoptosis of breast cancer cells.  |  Yang, Z., et al. 2024. Cancer Lett. 589: 216795. PMID: 38556106

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Stem-Cell Factor/c-Kit Inhibitor, ISCK03, 10 mg

sc-355981
10 mg
$199.00